Browsing by Subject "Glioma"
Now showing 1 - 2 of 2
- Results Per Page
- Sort Options
Item Astrocyte Elevated Gene-1, a Novel Modulator of Astrocyte Function: Implications for neuroAIDS, aging and glioblastoma(2013-12-01) Vartak, Neha; Ghorpade, AnujaVartak-Sharma, Neha N., Astrocyte elevated gene-1, a novel modulator of astrocyte function: Implications for NeuroAIDS, aging and glioblastoma. Doctor of Philosophy (Biomedical Sciences), Nov, 2013, 180 pp., 1 table, 40 illustrations, 336 bibliographies. Recent attempts to analyze human immunodeficiency virus (HIV)-1-induced gene expression changes in astrocyte identified a multifunctional oncogene, astrocyte elevated gene-1 (AEG-1), as an HIV-1 and tumor necrosis factor-inducible transcript. Subsequently, due to its homology to mouse breast cancer metastasis protein, metadherin, AEG-1 was largely implicated in carcinogenesis of diverse cancer types. However, the role of AEG-1 in astrocytes, the original cell type in which AEG-1 was first identified, still remains to be investigated. In the present study, we identified AEG-1 as a novel modulator of astrocyte function during reactive astrogliosis, neuroinflammation and neurodegeneration, and elucidated its implications in NeuroAIDS, aging and cancer. Our in vitro and in vivo studies recognized AEG-1 modulation of astrocyte migration and proliferation towards the wound site, thereby regulating astrocyte wound healing, a fundamental homeostatic function of astrocytes. Further, AEG-1 expression analyses in HIV-1+ and HIV-1 encephalitic human brain tissues provided the necessary physiological evidence for AEG-1 induction upon HIV-1 neuroinvasion. Herein, we identified AEG-1 as an inflammatory response gene and as an important upstream regulator of NF-κB signaling in astrocytes. Our results demonstrated AEG-1 cytoplasmic and nuclear interaction with NF-κB p65 subunit, which was crucial for NF-κB nuclear translocation, thereby regulating astrocyte neuroinflammation. In the same study, we also identified AEG-1 as a novel regulator of astrocyte glutamate clearance, an important determinant of neurocognitive CNS function, by modulating the expression of the key glutamate transporter, excitatory amino acid transporter 2. Analyses of AEG-1 expression in the cognitive centers of the brain of aging individuals demonstrated AEG-1 age-dependent expression in the human brain, which further proposed a role for AEG-1 in cellular oxidative stress responses. Herein, we identified a novel antioxidant cytoprotective role of AEG-1 in astrocytes and astrocytoma cells. Cellular localization studies by confocal microscopy revealed AEG-1 localization to the dense fibrillar components of the nucleolus in response to injury or oxidative stress, suggesting AEG-1 implication in ribosomal RNA processing. Our results demonstrated AEG-1 regulation of catalase activation and Nrf2 stabilization in response to oxidative stress and further elucidated AEG-1 modulation of Nrf2 nuclear translocation, the first step in antioxidant cellular defense mechanisms. The results presented in this thesis provide insight into the role of oncogene AEG-1 in human astrocytes and ameliorates our understanding of astrocyte-mediated processes in normal and disease-relevant pathologies, ranging from HIV-1-associated neurocognitive disorders and traumatic CNS injuries to primary neoplasms of the brain.Item Involvement of Estrogen Receptor Beta 5 in the Progression of Glioma(2013-05-01) Li, Wenjun; Shaohua YangEmerging evidence suggests a decline of ERβ expression in various peripheral cancers and ERβ has been proposed as a cancer brake that inhibits tumor cell growth and proliferation. In the current study, we have identified ERβ5 as the predominant isoform of ERβ in human glioma and its expression was significantly increased in human glioma as compared with non-neoplastic brain tissue. Hypoxia and activation of hypoxia inducible factor (HIF) increased ERβ transcription in U87 cells, suggesting elevated ERβ expression in glioma might be induced by the hypoxic stress in the tumor. Overexpression of either ERβ1 or ERβ5 increased PTEN expression and inhibited activation of the PI3K/AKT/mTOR pathway; ERβ5 also inhibited the MAPK/ERK pathway. In U87 cells, ERβ1 and ERβ5 decreased cell proliferation and decreased cells in the S+G2/M phase. Our findings suggest hypoxia induced ERβ5 expression in glioma as a self-protective mechanism against tumor proliferation and that ERβ5 might serve as a therapeutic target for the treatment of glioma. We also reported potential association between ERβ expression and outcomes of TMZ or tamoxifen treatment for GBM, which might be of practical clinical values.